Mounjaro
When Will Tirzepatide Go Generic? Patent Timeline & Biosimilar Outlook
Tirzepatide (Mounjaro for diabetes, Zepbound for obesity) is Eli Lilly’s blockbuster dual GIP/GLP-1 receptor agonist. SURMOUNT-1 (Jastreboff et al.
Tirzepatide Latest Research: New Indications, Trials & What’s Coming
The original tirzepatide trials targeted type 2 diabetes (SURPASS program) and obesity (SURMOUNT program).
Tirzepatide Who Should (and Shouldn’t) Take It: Eligibility & Contraindications
Introduction Tirzepatide has three FDA-approved indications as of 2026: type 2 diabetes (Mounjaro®), chronic weight management in adults with BMI 30+ or BMI 27+…
Tirzepatide Drug Interactions: What You Can and Can’t Take with It
Tirzepatide doesn’t have many serious drug interactions because it’s not metabolized through the CYP450 enzyme system the way most drugs are.
Tirzepatide Dosing Guide: Schedule, Titration & What to Expect Each Week
Tirzepatide for weight loss starts at 2.5 mg weekly and steps up every 4 weeks through 5, 7.5, 10, 12.5, and 15 mg.
Tirzepatide Dosage Chart: Every Dose Conversion in One Place
Tirzepatide has six approved dose strengths: 2.5, 5, 7.5, 10, 12.5, and 15 mg once weekly.
Tirzepatide Cost Breakdown: Brand, Compounded, Insurance & Savings Options
The cash price of brand tirzepatide is roughly $1,300 per month for Zepbound and $1,100 per month for Mounjaro without insurance.
Tirzepatide Diarrhea: Duration and Management
Tirzepatide diarrhea typically lasts 1 to 3 weeks per dose step and fades as the gut adapts. SURMOUNT-1 (Jastreboff et al.
Tirzepatide Constipation: Solutions That Work
Tirzepatide constipation affects roughly 11% to 17% of patients across SURMOUNT-1 (Jastreboff et al. 2022 NEJM) dose arms versus 6% on placebo.
